| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.78B | 111.55B | 128.19B | 120.52B | 114.00B | 110.21B |
| Gross Profit | 24.01B | 23.31B | 22.07B | 19.74B | 19.01B | 19.97B |
| EBITDA | 10.57B | 10.12B | 9.83B | 8.41B | 7.64B | 8.87B |
| Net Income | 4.94B | 4.54B | 4.46B | 3.43B | 3.33B | 4.55B |
Balance Sheet | ||||||
| Total Assets | 102.55B | 107.07B | 107.04B | 108.98B | 107.75B | 102.85B |
| Cash, Cash Equivalents and Short-Term Investments | 2.19B | 3.09B | 1.14B | 1.27B | 10.29B | 7.02B |
| Total Debt | 628.00M | 669.00M | 2.60B | 2.25B | 2.11B | 4.08B |
| Total Liabilities | 35.91B | 40.79B | 44.06B | 49.88B | 48.32B | 43.05B |
| Stockholders Equity | 66.63B | 66.28B | 62.98B | 59.10B | 59.42B | 59.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.43B | -1.19B | 110.00M | 6.00B | 5.80B |
| Operating Cash Flow | 0.00 | 8.78B | 2.06B | 2.95B | 9.10B | 8.50B |
| Investing Cash Flow | 0.00 | -3.28B | -4.80B | -4.75B | -2.61B | -2.43B |
| Financing Cash Flow | 0.00 | -3.56B | -894.00M | -3.73B | -3.23B | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥126.00B | 9.20 | ― | 2.85% | 8.02% | 4.39% | |
78 Outperform | ¥59.44B | 6.84 | ― | 4.09% | -6.09% | 31.18% | |
76 Outperform | ¥14.50B | 7.37 | ― | 3.03% | 5.72% | 60.38% | |
64 Neutral | ¥398.09B | 11.14 | ― | 3.62% | -0.03% | -42.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥42.57B | 6.79 | ― | 3.90% | 0.17% | 58.30% |